Vera Therapeutics Inc Class A (VERA)
$30.98 +1.47% Close Oct 30, 2026 Live
Vera Therapeutics stock today
Vera Therapeutics closed at $30.98 on October 30, 2026, up 1.47% on the day. Over the past year it returned +4.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.22 billion.
$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | VERA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.1% | -0.9% |
| 3 months | -6.3% | +2.1% |
| Year to date | -38.8% | +11.7% |
| 1 year | +4.4% | +12.4% |
| 3 years | +186.6% | +88.5% |
| 5 years | +60.1% | +76.0% |
Key statistics
- Market value
- $2.22B
- 52-week range
- $24.10 to $55.67
- Next report
- Nov 5, 2026
About Vera Therapeutics
Biopharmaceutical company developing treatments for kidney and metabolic diseases.
Sector: Health Care
More on Vera Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $1,601 today
No forecast, no recommendation. This page describes Vera Therapeutics Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.